Skip to main content
. Author manuscript; available in PMC: 2020 Jun 1.
Published in final edited form as: J Psychosom Res. 2019 Apr 12;121:68–73. doi: 10.1016/j.jpsychores.2019.04.004

Table 4.

Demographic and clinical characteristics of kidney transplant candidates with comorbid cannabis use disorders (based on listing status: denied/deferred vs listed/transplanted)

Characteristic Denied/Deferred
(n=34)
Listed/Transplanted
(n=27)
Total (n=61) p Value
Females 12 (35%) 9 (33%) 21 (34%) >0.99
Age at Initial Evaluation 45 45 45 0.86
White 23 (68%) 23 (85%) 46 (75%) 0.14
Married 9 (27%) 11 (41%) 20 (33%) 0.28
Psychiatric Follow-Up 16 (47%) 12 (44%) 28 (46%) >0.99
Sobriety Achieved 27 (79%) 27 (100%) 54 (89%) 0.01
Smokers at Initial Evaluation 13 (39) 10 (37%) 23 (38%) >0.99
Cannabis Use Daily 22 (67%) 13 (48%) 35 (58%) 0.19
History of Alcohol Dependence 19 (58%) 9 (33%) 28 (47%) 0.07
History of Alcohol Abuse 6 (18%) 10 (37%) 16 (27%) 0.14
History of Drug Dependence 11 (34%) 7 (26%) 18 (31%) 0.58
History of Drug Abuse 5 (16%) 3 (11%) 8 (14%) 0.72
Family History of SUD in First-Degree Relative 18 (58%) 16 (62%) 34 (59.6%) >0.99
Depressive Disorder 16 (49%) 9 (33%) 25 (42%) 0.30
Anxiety Disorder 7 (21%) 9 (33%) 16 (27%) 0.38